|
Volumn 21, Issue 1, 2010, Pages 37-42
|
Management of chronic allograft dysfunction by switch over to rapamycin.
a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
BIOLOGICAL MARKER;
CALCINEURIN;
CREATININE;
HEMOGLOBIN;
IMMUNOSUPPRESSIVE AGENT;
LIPID;
POTASSIUM;
RAPAMYCIN;
ADULT;
ALLOTRANSPLANTATION;
ARTICLE;
BLOOD;
CHRONIC DISEASE;
DRUG ANTAGONISM;
DRUG EFFECT;
FEMALE;
GLOMERULUS FILTRATION RATE;
GRAFT SURVIVAL;
HUMAN;
INDIA;
KAPLAN MEIER METHOD;
KIDNEY DISEASE;
KIDNEY TRANSPLANTATION;
MALE;
METABOLISM;
MIDDLE AGED;
MORTALITY;
PATHOPHYSIOLOGY;
RETROSPECTIVE STUDY;
TIME;
TREATMENT OUTCOME;
ADULT;
BIOLOGICAL MARKERS;
CALCINEURIN;
CHRONIC DISEASE;
CREATININE;
FEMALE;
GLOMERULAR FILTRATION RATE;
GRAFT SURVIVAL;
HEMOGLOBINS;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
INDIA;
KAPLAN-MEIERS ESTIMATE;
KIDNEY DISEASES;
KIDNEY TRANSPLANTATION;
LIPIDS;
MALE;
MIDDLE AGED;
POTASSIUM;
RETROSPECTIVE STUDIES;
SIROLIMUS;
TIME FACTORS;
TRANSPLANTATION, HOMOLOGOUS;
TREATMENT OUTCOME;
|
EID: 77949317502
PISSN: 13192442
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (4)
|
References (0)
|